Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes
出版年份 2020 全文链接
标题
Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes
作者
关键词
-
出版物
BRAIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-07-18
DOI
10.1093/brain/awaa262
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- GLP-1’s role in neuroprotection: a systematic review
- (2019) Damla Erbil et al. BRAIN INJURY
- Body mass index, diabetes, and the risk of Parkinson's disease
- (2019) Su‐Min Jeong et al. MOVEMENT DISORDERS
- Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
- (2018) Seung Pil Yun et al. NATURE MEDICINE
- Association between diabetes and subsequent Parkinson disease
- (2018) Eduardo De Pablo-Fernandez et al. NEUROLOGY
- Brain atrophy in middle-aged subjects with Type 2 diabetes mellitus, with and without microvascular complications
- (2018) Fang Fang et al. Journal of Diabetes
- Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson’s disease
- (2018) Raymond S. Schwartz et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Glitazone use associated with reduced risk of Parkinson's disease
- (2017) Brage Brakedal et al. MOVEMENT DISORDERS
- Propensity score analysis with partially observed covariates: How should multiple imputation be used?
- (2017) Clémence Leyrat et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study
- (2016) Per Svenningsson et al. MOVEMENT DISORDERS
- Insulin resistance and Parkinson’s disease: A new target for disease modification?
- (2016) D. Athauda et al. PROGRESS IN NEUROBIOLOGY
- Thiazolidinediones and Parkinson Disease: A Cohort Study
- (2015) John G. Connolly et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
- (2015) Ruth Brauer et al. PLOS MEDICINE
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
- (2012) Christian Hölscher CNS DRUGS
- Identifying periods of acceptable computer usage in primary care research databases
- (2012) Laura Horsfall et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis
- (2011) E. Cereda et al. DIABETES CARE
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started